Edward Miller

Net worth: 386 580 $ as of 30/03/2024

59 year

Health Technology

Consumer Services

Profile

Edward Miller is currently working as the Secretary & General Counsel at AlloVir, Inc. Previously, he held the position of Director-Finance & Accounting at Eloxx Pharmaceuticals, Inc. From 2014 to 2017, he served as the Chief Compliance Officer & Senior Vice President at Alexion Pharmaceuticals, Inc. Prior to that, he worked at Boehringer Ingelheim Corp.
as the Vice President & Associate General Counsel from 2000 to 2014.
Mr. Miller completed his undergraduate studies at Princeton University and obtained his graduate degree from Rutgers Law School.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
ALLOVIR INC 0.45%	21/04/2024	512,026 ( 0.45% )	386 580 $	30/03/2024

Edward Miller active positions

Companies	Position	Start
ALLOVIR, INC.	General Counsel	31/12/2018

All active positions of Edward Miller

Former positions of Edward Miller

Companies	Position	End
ALEXION PHARMACEUTICALS, INC.	Compliance Officer	30/04/2017
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.	General Counsel	31/12/2013
ELOXX PHARMACEUTICALS, INC.	Director of Finance/CFO	-

See the detail of Edward Miller's experience

Training of Edward Miller

Princeton University	Undergraduate Degree
Rutgers Law School	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Edward Miller's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ALLOVIR, INC.	Health Technology
ELOXX PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.	Health Technology
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT.	Health Technology

Private companies